Pmvp Stock Analysis Pmv Pharmaceuticals Inc Biotech Performance At 1.34 Price 20260403 1 Fed Governor Miran Submits Resignation Endorses Warsh as Next Chair BYD Eyes European Expansion Talks to Acquire Idle Plants from Stellantis Including Potential Maserati Link iRadimed Corporation IRMD Delivers Q1 2026 Beat EPS 049 vs 045 Expected Manhattan Bridge Capital LOAN Holds Steady Near MidRange Despite Low Volume First Citizens BancShares Preferred Stock FCNCO Holds Near 21 as Trading Range Defines Action Bionano Genomics BNGO Slips 16 as Stock Tests Key Support Near 116 Ernexa Therapeutics ERNA Slides 25 as Weakness Persists Near Support Levels Canadian Natural Resources CNQ Faces Selling Pressure After Steep Decline Emerson Electric EMR Gains Ground Resilience Amid Industrial Sector Trends Saris Secures 288 Million Series A to Accelerate Fintech Growth THG Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Improvements Chinas April Industrial Profits Surge 247 Fastest Growth in Over Two Years